Scholarlink

Background <p>This study aims to estimate the number of deaths and mortality rates associated with tobacco-related head and neck cancers (TRHNCs) from 1990 to 2019.</p> Methods <p>Detailed information on head and neck cancers from 1990 to 2019 was collected using data from the Global Burden of Disease (GBD) study 2019. The study reports the global number of deaths and mortality attributable to TRHNCs, along with the corresponding age-standardized death rates (ASDR).</p> Results <p>The number of deaths attributed to TRHNCs decreased from approximately 0.24 million in 1990 to around 0.15 million in 2019. The ASDR also showed a decline, dropping from 0.94 in 1990 to 0.73 in 2019.</p> Conclusions <p>The deaths of TRHNCs showed increased trends while the ASDR of TRHNCs have exhibited a significant decrease on a global scale. East Asia bears the heaviest disease burden of TRHNCs. The majority of this burden is observed in men, particularly among males aged 55 to 69&#xa0;years old.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Global tobacco-related head and neck cancer burden from 1990 to 2019: estimates from the global burden of disease study 2019

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月16日

查看全文
  • Xiang Bu,
  • Zhihan Liu,
  • Jing Liu,
  • Meng Lei

摘要

Background

This study aims to estimate the number of deaths and mortality rates associated with tobacco-related head and neck cancers (TRHNCs) from 1990 to 2019.

Methods

Detailed information on head and neck cancers from 1990 to 2019 was collected using data from the Global Burden of Disease (GBD) study 2019. The study reports the global number of deaths and mortality attributable to TRHNCs, along with the corresponding age-standardized death rates (ASDR).

Results

The number of deaths attributed to TRHNCs decreased from approximately 0.24 million in 1990 to around 0.15 million in 2019. The ASDR also showed a decline, dropping from 0.94 in 1990 to 0.73 in 2019.

Conclusions

The deaths of TRHNCs showed increased trends while the ASDR of TRHNCs have exhibited a significant decrease on a global scale. East Asia bears the heaviest disease burden of TRHNCs. The majority of this burden is observed in men, particularly among males aged 55 to 69 years old.